No Data
No Data
Express News | UBS Group's Long Position in H Shares of WuXi AppTec Decreases to 5.79% on April 25 From 6.31% - HKEX
[Brokerage Focus] Zhongtai International raised WUXI APPTEC (02359) to a "Buy" rating, indicating that the impact of USA tariffs is limited in the short term.
Jinwu Finance | According to a research report from Zhongtai International, WUXI APPTEC (02359) recorded a revenue increase of 21.0% year-on-year to 9.65 billion yuan (RMB, the same below) in the first quarter, with gross profit rising by 30.4% to 4.01 billion yuan, and shareholder net income increasing by 89.1% to 3.67 billion yuan. The Non-IFRS adjusted net income, reflecting the profitability of core business, increased by 40.0% year-on-year to 2.68 billion yuan. The revenue from the small molecule process R&D and production Sector and the TIDES (oligonucleotides and peptides) Sector rose by 13.8% and 187.6% year-on-year, respectively, accounting for nearly 80% of the company's revenue.
Hong Kong stocks are fluctuating | WUXI APPTEC (02359) has risen more than 5% again. Net profit in the first quarter increased by over 89%. Goldman Sachs stated that the company has room to raise guidance in the second half of the year.
WUXI APPTEC (02359) has risen more than 5% again, as of the time of this report, up 5.07%, priced at 63.2 Hong Kong dollars, with a transaction volume of 60.0461 million Hong Kong dollars.
WUXI APPTEC (02359) rose by 4.82%. The net profit in the first quarter increased by 89.06% year-on-year. Institutions expect the TIDES Business to grow by 65% this year.
Jingwu Financial News | WUXI APPTEC (02359) is experiencing strong fluctuations, up 4.82% as of this writing, reported at 63.05 Hong Kong dollars, with a transaction volume of 47.96 million Hong Kong dollars. In terms of news, WUXI APPTEC announced its earnings for the first quarter of 2025, with revenue of approximately 9.655 billion yuan, a year-on-year increase of 20.96%; the net income attributable to shareholders of the listed company is about 3.672 billion yuan, an increase of 89.06% year-on-year. As of the end of March 2025, the company's ongoing business orders amounted to 52.33 billion yuan, a year-on-year increase of 47.1%. Goldman Sachs released a research report indicating that WUXI APPTEC's first quarter earnings report was strong, the pipeline...
WuXi AppTec Co., Ltd. Just Beat EPS By 80%: Here's What Analysts Think Will Happen Next
[Brokerage Focus] China Merchants International maintains a Buy rating on WUXI APPTEC (02359) and points out that a good start in Q1 2025 helps the company cope with macro challenges.
Jingwu Financial News | Zhaoyin International Research Reports indicate that WUXI APPTEC (02359) announced impressive 1Q25 Earnings Reports, with revenue increasing by 21.0% year-on-year to 9.65 billion yuan. Among them, the Operation Business grew by 23.1% year-on-year, and the adjusted non-IFRS Net income increased significantly by 40.0% to 2.68 billion yuan. The revenue and profit growth rate continued the trend of quarterly improvement seen in 2024 and accelerated significantly in 1Q25. As of 1Q25, the company's Orders increased by 47.1% year-on-year to 52.33 billion yuan. Despite facing uncertainties in the macro environment, management maintained the annual business plan.